March 03, 2015 12:08 AM ET

Biotechnology

Company Overview of EOS (Ethical Oncology Science) S.p.A.

Company Overview

EOS (Ethical Oncology Science) S.p.A. develops drug product candidates for the treatment of cancer. It is primarily involved in the development of Lucitanib, an oral small-molecule tyrosine kinase inhibitor that is in Phase I/II development to prevent the development of new blood vessels essential for tumor growth and to interfere with tumor growth in certain FGF-dependent malignancies. The company was founded in 2006 and is based in Milan, Italy. As of November 19, 2013, EOS (Ethical Oncology Science) S.p.A. operates as a subsidiary of Clovis Oncology, Inc.

Via Monte di Pietà n.1/A

Milan, MI 20121

Italy

Founded in 2006

Phone:

39 02 87 39 16 08

Fax:

39 02 87 39 16 17

Key Executives for EOS (Ethical Oncology Science) S.p.A.

Co-Founder, Chairman of the Board and Chief Executive Officer
Age: 61
Co-Founder and Chief Operating Officer
Co-Founder
Age: 55
Co-Founder and Vice President of Operations
Compensation as of Fiscal Year 2014.

EOS (Ethical Oncology Science) S.p.A. Key Developments

Clovis Oncology, Inc., EOS S.p.A. - M&A Call

To discuss acquisition of EOS (Ethical Oncology Science) S.p.A.

Similar Private Companies By Industry

Company Name Region
MediaPharma s.r.l. Europe
Rottapharm Biotech S.r.l. Europe
Biocell Center S.p.a. Europe
Dialectica S.r.l. Europe
Notopharm S.r.l. Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EOS (Ethical Oncology Science) S.p.A., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.